HeartWare

6 Medtech Acquisitions That Went Horribly Wrong
6 Medtech Acquisitions That Went Horribly Wrong
Medical Devices and Diagnostics Industry
devices
Medtech
M&A
Medtronic
HeartWare
Second Sight Medical
Pixium Vision
Illumina
PacBio
Novartis
Alcon
Transcend
Organovo
Tarveda Therapeutics
Boston Scientific
Guidant
Flag link:
10 of the Most Controversial Deals in Medtech
10 of the Most Controversial Deals in Medtech
Medical Devices and Diagnostics Industry
devices
Medtech
M&A
FTC
Illumina
Pacific Biosciences
Google
Fitbit
HeartWare
Thoratec
Strkyer
Wright Medical
Organovo
Tarveda Therapeutics
Thermofisher
Qiagen
Second Sight Medical
Pixium Vision
Medtronic
Covidien
Grail
Abbott Labs
Alere
Flag link:
Medtronic's HeartWare HVAD ending brings questions about $1B acquisition
Medtronic's HeartWare HVAD ending brings questions about $1B acquisition
Medtech Dive
devices
Medtech
Medtronic
M&A
HeartWare
HVAD pump
Flag link:
Medtronic pulls HeartWare HVAD pump from market amid recalls, patient deaths
Medtronic pulls HeartWare HVAD pump from market amid recalls, patient deaths
Medtech Dive
Medtronic
devices
HeartWare
HVAD pump
patient deaths
Flag link:
Medtronic to buy Heartware in a $1.1 billion deal
Medtronic to buy Heartware in a $1.1 billion deal
Marketwatch
Medtronic
HeartWare
M&A
devices
Flag link:
HeartWare buys CircuLite for up to $350M
HeartWare buys CircuLite for up to $350M
Mass Device
devices
Circulite
HeartWare
M&A
Flag link:
FDA OKs HeartWare Device for Patients Awaiting Transplant
FDA OKs HeartWare Device for Patients Awaiting Transplant
FDA
HeartWare
patients
heart
Flag link:
FDA Decision Grows Near For Heartware
FDA Decision Grows Near For Heartware
FDA
HeartWare
Flag link:
HeartWare Completes WorldHeart Buy
HeartWare Completes WorldHeart Buy
HeartWare
WorldHeart
M&A
Flag link:
HeartWare Reports Second Quarter 2012 Results
HeartWare Reports Second Quarter 2012 Results
HeartWare
earnings
Flag link:
HeartWare names new CFO to boost commercialization efforts | Personnel Moves
HeartWare names new CFO to boost commercialization efforts | Personnel Moves
HeartWare
CFO
Management
Flag link:
HeartWare Product Makes Headway
HeartWare Product Makes Headway
HeartWare
heart
Flag link:
HeartWare lands CE Mark for long-term heart pump implant | Regulatory Roundup
HeartWare lands CE Mark for long-term heart pump implant | Regulatory Roundup
HeartWare
CE
Implant
regulatory
Flag link:
HeartWare Announces Publication Of Results From U.S. Bridge-To-Transplant Clinical Trial
HeartWare Announces Publication Of Results From U.S. Bridge-To-Transplant Clinical Trial
HeartWare
clinical trials
Flag link:
HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
HeartWare
clinical trial
patient
Flag link:
HeartWare's FDA nod is good news for rivals Abiomed, Thoratec
HeartWare's FDA nod is good news for rivals Abiomed, Thoratec
HeartWare
FDA
Abiomed
Thoratec
Flag link:
HeartWare Shares Rise on Panel Backing of Implantable Pump
HeartWare Shares Rise on Panel Backing of Implantable Pump
HeartWare
implants
Flag link:
FDA Advisory Panel Gives Green Light To HeartWare Ventricular Assist System
FDA Advisory Panel Gives Green Light To HeartWare Ventricular Assist System
FDA
HeartWare
Flag link:
HeartWare stock gains 4.5% as analysts predict FDA approval ahead of panel meeting
HeartWare stock gains 4.5% as analysts predict FDA approval ahead of panel meeting
HeartWare
stock
FDA
Flag link:
HeartWare Implant Pump Met Goals While FDA Questions Data
HeartWare Implant Pump Met Goals While FDA Questions Data
HeartWare
FDA
implants
Flag link:

Pages